Mario Encinas Selected Research

Mario Encinas Research Topics

Disease

10	Neoplasms (Cancer) 12/2023 - 08/2006
10	Endometrial Neoplasms (Endometrial Cancer) 12/2023 - 08/2006
3	Carcinogenesis 12/2023 - 04/2011
2	Carcinoma (Carcinomatosis) 12/2023 - 03/2017
2	Thyroid Neoplasms (Thyroid Cancer) 03/2017 - 07/2008
2	Neuroblastoma 04/2004 - 01/2002
1	Type 2 Diabetes Mellitus (MODY) 12/2023
1	Disease Progression 01/2022
1	Motor Neuron Disease (Primary Lateral Sclerosis) 01/2022
1	Cakut 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 03/2017
1	Neoplasm Metastasis (Metastasis) 03/2017
1	Renal Cell Carcinoma (Grawitz Tumor) 03/2017
1	Breast Neoplasms (Breast Cancer) 01/2017
1	Smith-Lemli-Opitz Syndrome 01/2016
1	Atherosclerosis 01/2015
1	Hypoxia (Hypoxemia) 06/2011
1	Microsatellite Instability 02/2011
1	Hereditary renal agenesis 02/2009
1	Alzheimer Disease (Alzheimer's Disease) 07/2006

Drug/Important Bio-Agent (IBA)

2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 11/2023 - 02/2011
2	TensinsIBA 11/2023 - 02/2011
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 02/2011
2	CarcinogensIBA 10/2021 - 01/2017
2	Tyrosine (L-Tyrosine)FDA Link 03/2017 - 02/2009
2	Phosphotransferases (Kinase)IBA 03/2017 - 06/2011
2	Small Interfering RNA (siRNA)IBA 06/2011 - 04/2011
2	NF-kappa B (NF-kB)IBA 07/2008 - 08/2006
2	Bortezomib (Velcade)FDA Link 02/2008 - 08/2006
2	Proteasome InhibitorsIBA 02/2008 - 08/2006
1	Metformin (Glucophage)FDA LinkGeneric 12/2023
1	Antineoplastic Agents (Antineoplastics)IBA 12/2023
1	Hypoglycemic Agents (Hypoglycemics)IBA 12/2023
1	Cre recombinaseIBA 11/2023
1	GalactosidasesIBA 01/2022
1	navitoclaxIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2019
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 03/2017
1	IodineIBA 03/2017
1	RNA (Ribonucleic Acid)IBA 03/2017
1	Sorafenib (BAY 43-9006)FDA Link 03/2017
1	Messenger RNA (mRNA)IBA 03/2017
1	MicroRNAs (MicroRNA)IBA 03/2017
1	Cyclin D1IBA 01/2017
1	Cell Cycle ProteinsIBA 01/2017
1	Cyclin DIBA 01/2017
1	palbociclibIBA 01/2017
1	CholesterolIBA 01/2016
1	Vitamin D FDA LinkGeneric 01/2015
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2015
1	LigandsIBA 04/2011
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2011
1	Complementary DNA (cDNA)IBA 04/2011
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 04/2011
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 04/2011
1	CateninsIBA 02/2011
1	Growth Factor ReceptorsIBA 02/2011
1	ParaffinIBA 02/2011
1	Proto-Oncogene Proteins c-retIBA 02/2009
1	benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA 02/2008
1	1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium SaltIBA 02/2008
1	EdaravoneIBA 02/2008
1	epoxomicinIBA 02/2008
1	AldehydesIBA 02/2008
1	AntioxidantsIBA 02/2008
1	Boronic AcidsIBA 02/2008
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2006
1	Transcription Factors (Transcription Factor)IBA 08/2006
1	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 07/2006
1	Nerve Growth Factor (NGF)IBA 07/2006
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2006
1	Proteins (Proteins, Gene)FDA Link 04/2004
1	Caspase InhibitorsIBA 01/2002
1	StaurosporineIBA 01/2002

Therapy/Procedure

2	Therapeutics 03/2017 - 06/2011
1	Adjuvant Radiotherapy 06/2011